Trial
NCT00551759
Chemotherapy, Radiation Therapy, and Cetuximab Followed by Surgery, Docetaxel, and Cetuximab in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer
Phase IITERMINATEDSAFETYConfidence: HIGH
Sponsor
Eastern Cooperative Oncology Group
Collaborators
National Cancer Institute (NCI)
Condition
Esophageal Cancer
Intervention
5-Fluorouracil
Why stopped
The study used a two-stage design. After stage one, the study was terminated due to excess toxicity.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-07-03